NCT03293628

Brief Summary

The LEEP conization is commonly used for cervical pathologies treatment. The techniques for hemostasis usually used are: cautery, Monsel's solution and vaginal pack. Actually, there is no consensus about the best technique and there is not much information that validates the use of some of that. To compare the use or not of vaginal pack as methods of hemostasis after LEEP conization for management of cervical lesions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Oct 2014

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2015

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2016

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

September 4, 2017

Completed
22 days until next milestone

First Posted

Study publicly available on registry

September 26, 2017

Completed
Last Updated

September 28, 2017

Status Verified

September 1, 2017

Enrollment Period

9 months

First QC Date

September 4, 2017

Last Update Submit

September 26, 2017

Conditions

Keywords

cervical intraepithelial neoplasiahaemostasisvaginal packLoop electrical excision procedurerandomized clinical trialsuterine cervical neoplasm

Outcome Measures

Primary Outcomes (1)

  • Vaginal bleeding until 30 days after surgery

    Bleeding was assessed by the need for reintervention.

    Until 30 days after surgery

Study Arms (2)

Conization With Vaginal Packing

EXPERIMENTAL

Experimental Arm. Haemostasis at the end of the procedure using vaginal packing and Monsel's solution.

Procedure: Vaginal Packing

Conization Without Vaginal Packing

ACTIVE COMPARATOR

Haemostasis at the end of the procedure using only Monsel's solution.

Procedure: Vaginal Packing

Interventions

This study will evaluate the role of vaginal packing after cervical conization as haemostasis technique

Conization With Vaginal PackingConization Without Vaginal Packing

Eligibility Criteria

Age19 Years - 68 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Indication of cervical conization.

You may not qualify if:

  • We excluded patients who were not treated by our department physicians or if the patient did not return for follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital do Câncer de Barretos

Barretos, São Paulo, 14784-400, Brazil

Location

MeSH Terms

Conditions

Uterine Cervical DysplasiaUterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by Site

Study Officials

  • Ricardo D Reis, MD

    Hospital do Câncer de Barretos

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The allocation of patients to one group or another was only known moments before the surgical procedure was started.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients were allocated in two arms (50 patients each): without vaginal pack (group 1 - GP1) and with vaginal pack (group 2 - GP2).Randomization was generated through a computer program creating a random entry list in the study, separating in group 1 (local application of Monsel's solution without intra-vaginal gauze buffer) and group 2 (application of Monsel's solution with intra-vaginal gauze). In this way, all patients had an equal chance of being included in both groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

September 4, 2017

First Posted

September 26, 2017

Study Start

October 1, 2014

Primary Completion

June 30, 2015

Study Completion

January 30, 2016

Last Updated

September 28, 2017

Record last verified: 2017-09

Locations